TGF-β Controls Stromal Telomere Length Through Epigenetic Modifications

Overview

Journal 3 Biotech

Publisher Springer

Specialty Biotechnology

Date 2022 Oct 24

PMID 36276465

Authors

Rajeev Mishra

Subhash Haldar

Shea Biondi

Vikash Kumar Bhari

Gyanendra Singh

Neil A Bhowmick

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-022-03346-5.

Citing Articles

The multifaceted role of the stroma in the healthy prostate and prostate cancer.

Di Carlo E, Sorrentino C J Transl Med. 2024; 22(1):825.

PMID: 39238004 PMC: 11378418. DOI: 10.1186/s12967-024-05564-2.

Cross-talk of Three Molecular Subtypes of Telomere Maintenance Defines Clinical Characteristics and Tumor Microenvironment in Gastric Cancer.

Yan M, Zhang Z, Wang L, Huang H, Wang J, Zhu C J Cancer. 2024; 15(10):3227-3241.

PMID: 38706908 PMC: 11064253. DOI: 10.7150/jca.92207.

References

Mehrez F, Bougatef K, Monache E, Arisi I, Proietti-De-Santis L, Prantera G . Telomere length measurement in tumor and non-tumor cells as a valuable prognostic for tumor progression. Cancer Genet. 2019; 238:50-61. DOI: 10.1016/j.cancergen.2019.07.007. View

Heaphy C, Yoon G, Peskoe S, Joshu C, Lee T, Giovannucci E . Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov. 2013; 3(10):1130-41. PMC: 3797255. DOI: 10.1158/2159-8290.CD-13-0135. View

Schoeftner S, Blasco M . A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J. 2009; 28(16):2323-36. PMC: 2722253. DOI: 10.1038/emboj.2009.197. View

Martinez P, Blasco M . Telomere-driven diseases and telomere-targeting therapies. J Cell Biol. 2017; 216(4):875-887. PMC: 5379954. DOI: 10.1083/jcb.201610111. View

Morin G . The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989; 59(3):521-9. DOI: 10.1016/0092-8674(89)90035-4. View

Hu H, Li B, Duan S . The Alteration of Subtelomeric DNA Methylation in Aging-Related Diseases. Front Genet. 2019; 9:697. PMC: 6333653. DOI: 10.3389/fgene.2018.00697. View

Cacchione S, Biroccio A, Rizzo A . Emerging roles of telomeric chromatin alterations in cancer. J Exp Clin Cancer Res. 2019; 38(1):21. PMC: 6337846. DOI: 10.1186/s13046-019-1030-5. View

Ao M, Williams K, Bhowmick N, Hayward S . Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res. 2006; 66(16):8007-16. PMC: 4067141. DOI: 10.1158/0008-5472.CAN-05-4451. View

Strell C, Paulsson J, Jin S, Tobin N, Mezheyeuski A, Roswall P . Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ. J Natl Cancer Inst. 2019; 111(9):983-995. PMC: 6748730. DOI: 10.1093/jnci/djy234. View

10.

Garcia-Cao M, OSullivan R, Peters A, Jenuwein T, Blasco M . Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet. 2004; 36(1):94-9. DOI: 10.1038/ng1278. View

11.

Liu S, Qi Y, Ge Y, Duplessis T, Rowan B, Ip C . Telomerase as an important target of androgen signaling blockade for prostate cancer treatment. Mol Cancer Ther. 2010; 9(7):2016-25. PMC: 2901418. DOI: 10.1158/1535-7163.MCT-09-0924. View

12.

Mishra R, Haldar S, Suchanti S, Bhowmick N . Epigenetic changes in fibroblasts drive cancer metabolism and differentiation. Endocr Relat Cancer. 2019; 26(12):R673-R688. PMC: 6859444. DOI: 10.1530/ERC-19-0347. View

13.

Zhang H, Chen X, Wang M, Wang J, Qi Q, Zhang R . Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin Cancer Res. 2004; 10(7):2359-67. DOI: 10.1158/1078-0432.ccr-0959-3. View

14.

Coppe J, Desprez P, Krtolica A, Campisi J . The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010; 5:99-118. PMC: 4166495. DOI: 10.1146/annurev-pathol-121808-102144. View

15.

Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K . Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A. 2008; 105(32):11299-304. PMC: 2516278. DOI: 10.1073/pnas.0801457105. View

16.

Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, Spicer D . Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem. 2010; 285(23):17556-63. PMC: 2878520. DOI: 10.1074/jbc.M109.076414. View

17.

Vakoc C, Mandat S, Olenchock B, Blobel G . Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell. 2005; 19(3):381-91. DOI: 10.1016/j.molcel.2005.06.011. View

18.

Tardat M, Dejardin J . Telomere chromatin establishment and its maintenance during mammalian development. Chromosoma. 2017; 127(1):3-18. PMC: 5818603. DOI: 10.1007/s00412-017-0656-3. View

19.

Jezek M, Green E . Histone Modifications and the Maintenance of Telomere Integrity. Cells. 2019; 8(2). PMC: 6407025. DOI: 10.3390/cells8020199. View

20.

Zhang Q, Chen L, Helfand B, Jang T, Sharma V, Kozlowski J . TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. PLoS One. 2011; 6(9):e25168. PMC: 3184137. DOI: 10.1371/journal.pone.0025168. View